OPKO Health, Inc. beat EPS estimates 62% of the time across 16 reported quarters (10 beats, 6 misses), averaging -10.3% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $-0.01 | not reported | not reported | Q2 FY26 call |
| Q1 FY26 | $-0.07 | $-0.07 | +0.0% | Beat | |
| Q4 FY25 | $-0.07 | $-0.04 | +42.9% | Beat | |
| Q3 FY25 | not reported | $0.03 | not reported | not reported | |
| Q2 FY25 | $-0.12 | $-0.19 | -58.3% | Miss | |
| Q1 FY25 | $-0.06 | $-0.10 | -66.7% | Miss | |
| Q4 FY24 | not reported | $0.01 | not reported | not reported | |
| Q3 FY24 | not reported | $0.03 | not reported | not reported | |
| Q2 FY24 | not reported | $-0.01 | not reported | not reported | |
| Q1 FY24 | $-0.09 | $-0.12 | -33.3% | Miss | |
| Q4 FY23 | $-0.09 | $-0.09 | +0.0% | Beat | |
| Q3 FY23 | $-0.09 | $-0.11 | -22.2% | Miss |
Back to OPK overview · OPK holders · OPK KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.